Diferenzas entre revisións de «Proxestáxeno»

A proxestina sintética ''[[ciproterona]]'' utilizase como [[antiandróxeno]] <ref>A Juul, T Scheike, C T Nielsen, S Krabbe, J Müller and N E Skakkebaek. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate). The Journal of Clinical Endocrinology & Metabolism October 1, 1995 vol. 80 no. 10 3059-3067
doi: 10.1210/jc.80.10.3059 [http://jcem.endojournals.org/content/80/10/3059.short]</ref>. Outras proxestinas, polo contrario, teñen propiedades androxénicas <ref>Linn ES. Clinical significance of the androgenicity of progestins in hormonal therapy in women. Clin Ther. 1990 Sep-Oct;12(5):447-55. [http://www.ncbi.nlm.nih.gov/pubmed/2268868]</ref>.
===Hemorraxia por retirada de proxesterona===